Combined Tetanus, Diphtheria, and 5-Component Pertussis Vaccine for Use in Adolescents and Adults—Correction

December 2005
JAMA: Journal of the American Medical Association;12/28/2005, Vol. 294 Issue 24, p3092
Academic Journal
Correction notice
Presents a correction to the article "Combined Tetanus, Diphtheria, and 5-Component Pertussis Vaccine for Use in Adolescents and Adults" in the June 22/299, 2005 issue.


Related Articles

  • Cellular and Acellular Pertussis Vaccines in Adults. Keitel, Wendy A. // Clinical Infectious Diseases;6/2/1999, Vol. 28, pS118 

    Examines the cellular and acellular pertussis vaccines in adults. Immunization of adults with whole cell pertussis vaccines; Acellular pertussis vaccines; History of acellular pertussis vaccine development.

  • Indications for Acellular Pertussis Vaccines in Adults: The Case for Selective, Rather than... Gardner, Pierce // Clinical Infectious Diseases;6/2/1999, Vol. 28, pS131 

    Discusses the indications for acellular pertussis vaccines in adults. Primary principles of vaccine policy; Determinants of vaccine priority; Pertussis epidemiology in adults; Clinical significance of pertussis in adults; Goals of pertussis immunization of adults; Strategy options to prevent...

  • Pertussis in Adults: Epidemiology, Signs, Symptoms, and Implications for Vaccination. Orenstein, Walter A. // Clinical Infectious Diseases;6/2/1999, Vol. 28, pS147 

    Discusses the epidemiology, signs, symptoms and implications for vaccination of pertussis in adults. Burden of pertussis in adults; Adult pertussis in childhood illness; Adult vaccine program; Safety of adult vaccine; Effectiveness of booster doses; Comparisons of various vaccines; Costs of...

  • Effectiveness of Acellular Pertussis Vaccine Assessed by Hospital-Based Active Surveillance in Germany. Juretzko, P.; von Kries, R.; Hermann, M.; von Konig, C.H. Wirsing; Weil, J.; Giani, G. // Clinical Infectious Diseases;7/15/2002, Vol. 35 Issue 2, p162 

    Focuses on a study which assessed the efficacy of pertussis vaccine after partial and completed primary vaccination series for preventing hospitalizations due to pertussis in Germany. Methodology; Incidence of pertussis in the country; Vaccination status of hospitalized children with pertussis;...

  • Toxicity of pertussis vaccine. Preston, Noel W. // British Medical Journal (Clinical Research Edition);6/19/1982, Vol. 284 Issue 6332, p1817 

    Examines the toxicity and efficacy of pertussis vaccine in Great Britain. Cause of continuing low level of vaccination; Components of pertussis vaccine; Correlation between histamine and immunogens.

  • Progress towards a new pertussis vaccine. Miller, Elizabeth // British Medical Journal (Clinical Research Edition);5/24/1986, Vol. 292 Issue 6532, p1348 

    Focuses on the developments in the use of pertussis vaccine. Risks and benefits of vaccination; Components of whole cell vaccine; Frequency of minor postvaccination symptoms.

  • Acellular pertussis vaccine recommendations.  // American Family Physician;10/1/1996, Vol. 54 Issue 5, p1805 

    Focuses on recommendations from the Advisory Committee on Immunization Practices on the administering of acellular pertussis vaccine on children before they reach the age of seven years. Information on the approval of the combination of diptheria and tetanus toxoids and acellular pertussus...

  • Pertussis immunisation of children with histories of neurological problems. Baxter, D.N. // BMJ: British Medical Journal (International Edition);12/17/94, Vol. 309 Issue 6969, p1619 

    Describes the pertussis immunization of children with histories of neurological problems in Great Britain. Formulation of guidelines for using vaccine; Focus on the occurrence of serious adverse reactions; Concentrations of antibodies to diphtheria, tetanus and three pertussis serotypes.

  • Acellular pertussis vaccines are safe and immunogenic for infants.  // Modern Medicine;Feb97, Vol. 65 Issue 2, p60 

    Presents an abstract of the study `The Multicenter Acellular Pertussis Trial: An overview,' by M.D. Decker and K.M. Edwards published in the November 1996 issue of the `Journal of Infectious Diseases.'

  • Effects of Pertussis Vaccination on Disease: Vaccine Efficacy in Reducing Clinical Severity. Preziosi, Marie-Pierre; Halloran, M. Elizabeth // Clinical Infectious Diseases;9/15/2003, Vol. 37 Issue 6, p772 

    Estimates the effectiveness of pertussis vaccination in reducing the clinical severity of breakthrough disease among vaccinated individuals from a comprehensive follow-up study of a community of 30,000 residents of Niakhar, Senegal. Collection of samples from children for culture or serologic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics